Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

3 Stocks Ready to Climb Higher
3 Stocks Ready to Climb Higher

Investing in individual stocks can be a rocky road. Our job as investors is to find high-quality stocks at great prices with bright futures.

In today's video, I will be discussing three stocks

5 Top Stocks to Buy in November
5 Top Stocks to Buy in November

As we wind down 2025, the markets are looking shaky and I want my portfolio to be well diversified in the case of a recession or market correction. As such, in today's video I am going to take all

Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring
Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring

A strong quarter and earnings beat can sometimes give a stock a big boost. But when that doesn't happen, it usually means there are other factors that are weighing on a business and give investors

Why AstraZeneca Stock Was a Winner Today
Why AstraZeneca Stock Was a Winner Today

Good news from the laboratory put some zip into AstraZeneca (NASDAQ: AZN) shares on Monday. The veteran pharmaceutical company's shares enjoyed a nearly 3% lift across the trading session as a

Why Roche Holding Stock Popped Today
Why Roche Holding Stock Popped Today

Roche Holding (OTC: RHHBY) stock jumped 3.4% through 1:05 p.m. ET Monday after the pharmaceutical giant's Genentech subsidiary announced positive phase 3 clinical trial results for its fenebrutinib

This Is Why Royal Caribbean Is the Only Major Cruise Line Stock I Own
This Is Why Royal Caribbean Is the Only Major Cruise Line Stock I Own

Until a few weeks ago, I was more than happy to own shares in all three of the major cruise line stocks. Royal Caribbean (NYSE: RCL) was my largest of the three positions, followed by Carnival

After Boosting Its Guidance and Beating Expectations in Q3, Is UnitedHealth Stock Due for a Rally?
After Boosting Its Guidance and Beating Expectations in Q3, Is UnitedHealth Stock Due for a Rally?

UnitedHealth Group (NYSE: UNH) used to be a safe stock to hang on to. Its financials looked impressive, the business got bigger, it boosted its dividend, and it looked like a no-brainer stock to

2 Monster Stocks in the Making
2 Monster Stocks in the Making

There's nothing wrong with investing in well-known, market-leading corporations. Many still have excellent prospects and robust underlying businesses. However, it's also worth considering smaller

Is There a Future for Viking Therapeutics?
Is There a Future for Viking Therapeutics?

After the release of the top-line results from its phase 2 clinical trial of its lead drug candidate, VK2735 (oral formulation), in August, there were investors who doubted whether Viking

Got $5,000? These Are 3 of the Cheapest Growth Stocks to Buy Right Now
Got $5,000? These Are 3 of the Cheapest Growth Stocks to Buy Right Now

A $5,000 investment may not seem like a large amount of money to invest in the stock market. But you can make the most of it by investing for the long haul, and picking modestly valued growth

SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million
SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million

SG Capital Management LLC reduced its holding in Haemonetics Corporation (NYSE:HAE) by 731,892 shares, a position value decline of $59,133,712, per November 07, 2025, SEC filings.

According to a fil

2 No-Brainer Dividend Stocks to Buy With $100 in November
2 No-Brainer Dividend Stocks to Buy With $100 in November

The stock market caters to investors with almost any budget, especially with online brokers offering commission-free trading and fractional shares. Even with a modest sum, you can find quality

Why Haemonetics Stock Was on Fire Thursday
Why Haemonetics Stock Was on Fire Thursday

Niche healthcare stock Haemonetics (NYSE: HAE) was a winner among the clutch of publicly traded companies reporting quarterly earnings on Thursday. On the back of an estimates-beating second quarter

Crucial Updates from AMD, Nvidia, Super Micro, and Other AI Stocks
Crucial Updates from AMD, Nvidia, Super Micro, and Other AI Stocks

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD), Nvidia (NASDAQ: NVDA), and other artificial intelligence stocks. To learn more, check out the short video,

Big News Is Coming for AMD Investors on Nov. 11. Should You Buy AMD Stock Now?
Big News Is Coming for AMD Investors on Nov. 11. Should You Buy AMD Stock Now?

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special

2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street
2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street

The "Magnificent Seven" stocks, a group of (mostly) tech giants, are among the most covered companies on Wall Street. The general sentiment about these corporations is that they boast attractive

EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.
Here's How Nvidia, AMD, and Broadcom Could Help This Super Semiconductor ETF Turn $500 Per Month Into $1 Million
Here's How Nvidia, AMD, and Broadcom Could Help This Super Semiconductor ETF Turn $500 Per Month Into $1 Million

Every new generation of artificial intelligence (AI) model typically soaks up more data center computing capacity than the last. The latest batch of reasoning models spend more time "thinking" in

EQS-News: STRATEC REPORTS DEFINITIVE RESULTS FOR FIRST NINE MONTHS OF 2025
EQS-News: STRATEC REPORTS DEFINITIVE RESULTS FOR FIRST NINE MONTHS OF 2025
EQS-News: STRATEC REPORTS DEFINITIVE RESULTS FOR FIRST NINE MONTHS OF 2025
What Did Goldman Sachs and Morgan Stanley CEOs Say to Spook the Market?
What Did Goldman Sachs and Morgan Stanley CEOs Say to Spook the Market?

The U.S. stock market turned sharply lower Tuesday morning in reaction to seemingly negative comments by the CEOs of Morgan Stanley (NYSE: MS) and Goldman Sachs (NYSE: GS). At the Global Financial

Why AstraZeneca Stock Topped the Market on Thursday
Why AstraZeneca Stock Topped the Market on Thursday

Veteran pharmaceutical company AstraZeneca (NASDAQ: AZN) delivered for investors on the second-to-last trading day of the week. Its shares rose by more than 3% across that trading session, thanks

Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings
Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings

On Tuesday, Baltimore-based Brown Capital Management reported selling 861,020 shares of Vericel Corporation for an estimated $30.9 million based on the average share price in the third quarter.

AMD Earnings: The Good and the Bad
AMD Earnings: The Good and the Bad

In this video, I will cover Advanced Micro Devices' (NASDAQ: AMD) latest earnings results and explain why the stock dropped despite an excellent quarter. Watch the short video to learn more

3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November
3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November

The stock market is near all-time highs as Wall Street chugs through earnings season and eyes the end of the year just around the corner.

But not all stocks are hitting new heights. Some prominent

Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off
Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off

Baltimore-based Brown Capital Management reported a sale of 376,359 Glaukos Corporation shares for an estimated $34.6 million in the third quarter, according to an SEC filing.

Brown Capital